A Prospective and Comparative Study of the Performance of Tension Free Vaginal Mesh (Prolift) Versus Conventional Vaginal Prolapse Surgery in Recurrent Prolapse
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Pelvic Organ Prolapse
- Sponsor
- Radboud University Medical Center
- Enrollment
- 194
- Locations
- 13
- Primary Endpoint
- Prolapse by "Pelvic Organ Prolapse Quantification System" (POP-Q), at 12 Months
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
Pelvic organ prolapse is a common problem. A lot of women have surgery for prolapse. The recurrence rate op pelvic organ prolapse after surgical treatment is high. Placement of a mesh aims at reducing the recurrence rate, but mesh implants can cause complications.
This study is designed to determine the effectiveness of one type of mesh (tensionfree vaginal mesh; Prolift), compared with the standard prolapse surgery. A secondary objective is to track the complications of both procedures.
Detailed Description
Patients with recurrent prolapse after surgery can participate in this study. A total of 194 women will be included. At random 97 patients undergo a standard prolapse operation and 97 patients undergo an operation with the mesh. Evaluation will take place during surgery, at the postoperative visit after six weeks, and after six months and twelve months. Quality of life, degree of vaginal prolapse, subjective effectiveness, safety and incidence of complications will be evaluated. An amendment to the original study has been approved by the Ethical Committee to examine long term outcome of this RCT at 7 years. This study was completed in december 2015.
Investigators
Mariella Withagen
Principal Investigator
Radboud University Medical Center
Eligibility Criteria
Inclusion Criteria
- •recurrent anterior and/or posterior prolapse POP-Q stage 2 or more
- •patient has agreed to undergo implantation of TVM (prolift) or fascial plication
- •patient is willing to return for follow-up evaluation at 6 weeks, 6 months and 12 months
- •patient is willing to complete quality of life questionnaires at 6 and 12 months
Exclusion Criteria
- •patient is or wants to become pregnant
- •patient has had previous synthetic mesh procedure (a previous mid-urethral sling procedure is NOT an exclusion criterion)
- •patient has current urinary tract or vaginal infections
- •patient has a blood coagulation disorder
- •patient has a compromised immune system or any other condition that would compromise healing
- •patient has renal insufficiency and/or upper urinary tract obstruction
- •patient is unwilling or unable to return for evaluation
- •patient has had previous irradiation
- •patient has any malignancy
- •patient has large ovarian cysts of large myoma
Outcomes
Primary Outcomes
Prolapse by "Pelvic Organ Prolapse Quantification System" (POP-Q), at 12 Months
Time Frame: 12 months
Number of participants with anatomic failures defined as "Pelvic Organ Prolapse" (POP) stage II or higher
Secondary Outcomes
- Bulge Symptoms(12 months)
- Mesh Exposure at 12 Months(12 months)
- "Patient Global Impression of Improvement" (PGI-I) at 12 Months(at 12 months)